News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
584,550 Results
Type
Article (46760)
Company Profile (171)
Press Release (537619)
Section
Business (164094)
Career Advice (2576)
Deals (29821)
Drug Delivery (103)
Drug Development (75731)
Employer Resources (153)
FDA (13864)
Job Trends (13190)
News (289047)
Policy (28091)
Tag
Academia (2594)
Alliances (42150)
Alzheimer's disease (1354)
Approvals (13835)
Artificial intelligence (207)
Bankruptcy (320)
Best Places to Work (10469)
Biotechnology (140)
Breast cancer (217)
Cancer (1702)
Cardiovascular disease (138)
Career advice (2149)
CAR-T (131)
Cell therapy (370)
Clinical research (60968)
Collaboration (646)
Compensation (235)
COVID-19 (2531)
C-suite (173)
Data (1611)
Diabetes (212)
Diagnostics (5790)
Earnings (57506)
Employer resources (139)
Events (84697)
Executive appointments (582)
FDA (14721)
Funding (586)
Gene therapy (265)
GLP-1 (662)
Government (4153)
Healthcare (16416)
Infectious disease (2649)
Inflammatory bowel disease (125)
Interviews (528)
IPO (13443)
Job creations (3135)
Job search strategy (1781)
Layoffs (437)
Legal (6095)
Lung cancer (262)
Manufacturing (229)
Medical device (10652)
Medtech (10656)
Mergers & acquisitions (16720)
Metabolic disorders (563)
Neuroscience (1791)
NextGen: Class of 2025 (5812)
Non-profit (4056)
Northern California (1865)
Obesity (304)
Opinion (237)
Patents (161)
People (53632)
Phase I (18996)
Phase II (26889)
Phase III (20225)
Pipeline (723)
Postmarket research (2357)
Preclinical (7809)
Radiopharmaceuticals (229)
Rare diseases (332)
Real estate (4994)
Regulatory (19527)
Research institute (2221)
Resumes & cover letters (383)
Southern California (1664)
Startups (3258)
United States (16551)
Vaccines (613)
Weight loss (218)
Date
Today (118)
Last 7 days (587)
Last 30 days (2371)
Last 365 days (31999)
2025 (4255)
2024 (32578)
2023 (36252)
2022 (46925)
2021 (50434)
2020 (48452)
2019 (41461)
2018 (31529)
2017 (29013)
2016 (27716)
2015 (32200)
2014 (26133)
2013 (22320)
2012 (21469)
2011 (22435)
2010 (20016)
Location
Africa (807)
Arizona (137)
Asia (36449)
Australia (7356)
California (4295)
Canada (1592)
China (384)
Colorado (189)
Connecticut (199)
Europe (81635)
Florida (638)
Georgia (135)
Illinois (424)
Indiana (240)
Maryland (693)
Massachusetts (3183)
Michigan (182)
Minnesota (290)
New Jersey (1238)
New York (1247)
North Carolina (771)
Northern California (1865)
Ohio (148)
Pennsylvania (942)
South America (1101)
Southern California (1664)
Texas (638)
Utah (138)
Washington State (448)
584,550 Results for "pharmacyte biotech formerly known as nuvilex".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
PharmaCyte Biotech, Inc. today announced a $7 million investment in MyMD Pharmaceuticals, Inc.
May 21, 2024
·
4 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Business
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (“Femasys”), a biomedical company focused on meeting significant unmet needs for women worldwide.
November 15, 2023
·
4 min read
Leadership
Biotech CEO Sisterhood Fills ‘Unmet Need’ for Fellowship Among Women Leaders
At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of women and allies in biopharma as their authentic selves.
February 5, 2025
·
4 min read
·
Annalee Armstrong
Business
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
Femasys Inc. today announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech, Inc. (Nasdaq: PMCB) and other healthcare investors.
November 15, 2023
·
6 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Editorial
Sarepta, Biotech’s Regulatory Go-Getter, Signs Standout Rare Disease Deal
Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead Pharmaceuticals on RNAi-based medicines.
December 4, 2024
·
3 min read
·
Annalee Armstrong
Legal
Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug
Back in 2023, Novo Nordisk committed up to $1.3 billion for a hypertension and kidney disease drug from KBP Biosciences. Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree.
February 18, 2025
·
1 min read
·
Annalee Armstrong
Cystic Fibrosis
Cystic Fibrosis Biotech Sionna Announces $150M IPO
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space dominated by Vertex.
February 3, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 58,455
Next
